Generates revenue from selling non-invasive aesthetic medical device systems and related applicators to physician customers. It also earns recurring revenue from consumable digital pulse packages required to operate the systems.
Geographic Exposure
North America58.92%
Eastern Asia28.29%
Europe10.73%
Middle East10.73%
Latin America2.05%
Revenue Drivers
System and applicator sales
Sales of Sofwave systems bundled with an initial pulse package.
CORE60.9%
Recurring pulse consumables
Ongoing sales of digital pulse packages used during treatments.
CORE39.1%
End Markets
Plastic surgeons
Dermatologists
Aesthetic medicine physicians
Clinics and medical spas
Medical device distributors
Specializations
SUPERB ultrasound platform (Parallel Beam Synchronous)Integrated cooling mechanism for epidermis protectionFDA 510(k) clearances for aesthetic indicationsCE Mark and multi-jurisdiction regulatory approvalsMulti-site clinical trials and clinical studiesIoT-enabled remote upgrades and pulse-usage monitoring+2 more
Activities
Research and development of energy-based aesthetic devices
Regulatory clearance and clinical validation
Outsourced contract manufacturing and supply-chain management
